CAVIN4
Basic information
Region (hg38): 9:100578079-100588389
Previous symbols: [ "MURC" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAVIN4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | 17 | ||||
missense | 44 | 51 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 12 | |||||
Total | 0 | 0 | 49 | 27 | 10 |
Variants in CAVIN4
This is a list of pathogenic ClinVar variants found in the CAVIN4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-100578087-G-A | Benign (Jun 18, 2018) | |||
9-100578134-A-T | not specified | Uncertain significance (Dec 23, 2015) | ||
9-100578154-A-G | Uncertain significance (May 18, 2018) | |||
9-100578171-G-A | Uncertain significance (Jan 16, 2017) | |||
9-100578192-C-T | not specified | Uncertain significance (Nov 21, 2023) | ||
9-100578199-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
9-100578200-G-A | not specified • CAVIN4-related disorder | Benign/Likely benign (Aug 26, 2020) | ||
9-100578202-G-C | not specified | Uncertain significance (Mar 29, 2024) | ||
9-100578214-A-T | not specified | Uncertain significance (May 30, 2023) | ||
9-100578227-C-T | not specified | Likely benign (Sep 11, 2019) | ||
9-100578228-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
9-100578271-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
9-100578281-T-G | Uncertain significance (Sep 15, 2022) | |||
9-100578292-G-A | Uncertain significance (Oct 15, 2020) | |||
9-100578304-T-C | Uncertain significance (Sep 06, 2017) | |||
9-100578304-T-G | Uncertain significance (Jan 16, 2017) | |||
9-100578311-G-C | Uncertain significance (Dec 15, 2020) | |||
9-100578320-G-A | Likely benign (Feb 12, 2020) | |||
9-100578345-G-A | not specified | Uncertain significance (Aug 12, 2022) | ||
9-100578361-T-C | not specified | Uncertain significance (Jan 04, 2024) | ||
9-100578376-C-T | not specified | Benign (Oct 20, 2016) | ||
9-100578384-A-G | not specified | Uncertain significance (Nov 22, 2023) | ||
9-100578386-T-G | not specified | Conflicting classifications of pathogenicity (Dec 13, 2021) | ||
9-100578424-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
9-100578433-G-A | not specified | Uncertain significance (May 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAVIN4 | protein_coding | protein_coding | ENST00000307584 | 2 | 9828 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000505 | 0.685 | 125660 | 0 | 87 | 125747 | 0.000346 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.632 | 225 | 200 | 1.13 | 0.0000107 | 2416 |
Missense in Polyphen | 87 | 75.34 | 1.1548 | 919 | ||
Synonymous | 0.123 | 78 | 79.4 | 0.982 | 0.00000464 | 688 |
Loss of Function | 0.930 | 8 | 11.4 | 0.703 | 6.53e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000822 | 0.000822 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000528 | 0.000489 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000298 | 0.000290 |
Middle Eastern | 0.000528 | 0.000489 |
South Asian | 0.000295 | 0.000294 |
Other | 0.00108 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Modulates the morphology of formed caveolae in cardiomyocytes, but is not required for caveolar formation. Facilitates the recruitment of MAPK1/3 to caveolae within cardiomyocytes and regulates alpha-1 adrenergic receptor-induced hypertrophic responses in cardiomyocytes through MAPK1/3 activation. Contributes to proper membrane localization and stabilization of caveolin-3 (CAV3) in cardiomyocytes (By similarity). Induces RHOA activation and activates NPPA transcription and myofibrillar organization through the Rho/ROCK signaling pathway (PubMed:18332105). {ECO:0000250|UniProtKB:A2AMM0, ECO:0000269|PubMed:18332105}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 32.06
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Cavin4
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- cavin4b
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- irregularly shaped
Gene ontology
- Biological process
- muscle organ development;regulation of gene expression;cell differentiation;regulation of Rho protein signal transduction;positive regulation of transcription by RNA polymerase II
- Cellular component
- cytoplasm;cytosol;plasma membrane;caveola;Z disc;sarcolemma
- Molecular function
- protein binding